In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vital Images Inc.

Division of Canon Inc.
www.vitalimages.com

Latest From Vital Images Inc.

Deals Shaping the Medical Industry (09/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

SOVAmed GMBH

SOVAmed, a technology spin-off from the University of Koblenz-Landau in Germany, develops visualization and analysis tools that support vascular surgeons and interventional radiologists. SOVAmed's lead application, SOVA.evar, is designed to detect AAAs and evaluate clinically significant parameters more accurately and rapidly than existing technologies.
Medical Device

The Unstable State of Plaque Detection

Recent research points to unstable, rather than stenotic plaque, as a major cause of heart attacks. Cardiologists, as much as entrepreneurs and large companies, are therefore driving the creation of new cardiac detection platforms based on characterizing arterial plaque in order to identify patients that are unaware that they are at risk of suffering a myocardial infarction. First-generation detection tools are well along in development, but the scientific understanding about plaque is evolving so rapidly, technologies may be obsolete by the time they are ready for commercialization. Finally, looking for heart attack risk in symptomless patients means screening apparently healthy patients based on risk factors. Clinicians aren't yet prepared for the treatment implications and payers aren't ready for the economic burden of widespread screening, and this presents one of the greatest challenges for companies introducing new plaque detection technologies.
Medical Device Strategy
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Canon Inc.
  • Senior Management
  • Jay D Miller, Pres. & CEO
    Steven P Canakes, VP, Sales
    Jeremy A Abbs, VP, Mktg.
  • Contact Info
  • Vital Images Inc.
    Phone: (952) 487-9500
    5850 Opus Pkwy., Ste. 300
    Minnetonka, MN 55343-4414
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register